Antti Sakari Rannikko

21PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersPacific Peoples sport and physical activityIntelligent roboticsEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 15, 2025
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.

Abderrahim-Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto

|Dec 10, 2025
Erectile and urinary function in patients on active surveillance for prostate cancer: results from the Finnish arm of the PRIAS trial.

Oleg Kerro, Inari Kalalahti, Utku Lokman

|Sep 02, 2025
Artificial intelligence for prostate cancer diagnostics.

Antti S Rannikko

|Apr 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.

Ivo I de Vos, Cristina Marenghi, Fabio Badenchini

|Mar 27, 2025
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK.

Ugo De Giorgi, Stephen J Freedland, Antti Rannikko

|Jan 22, 2025
Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result.

Juho Pylväläinen, Kirsi Talala, Jani Raitanen

Pageof 4

Frequent Collaborators

11 joint publications

Tuomas Mirtti

4 joint publications

Anu Kenttämies

4 joint publications

Andrew M Erickson

4 joint publications

Timo-Pekka Lehto